Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDAP1L1 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-06 |
mRNA | PARP11 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | SCN3A | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | AP000322.53 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | LRCH4 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | TGFBRAP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | FSD1L | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | FAM19A1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | CHD7 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |